OPGN BACK to $4 NOW, Open LONG!!! $$$$11.5 million funding on the way, retail investors with their eye on it, recently trading at 1000%. Back to $4 in a matter of days! LETS GOOO!!OLongby rsantanabookingUpdated 1
OPGN 1W headed to AFinally a trip to the top of the down channel. How exciting for OPGN holders yesterday as they finally felt the sting lessen. $4.43 is is the target price. Lets go! OPGEN INC. OpGen, Inc. is a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease. It engages in the development of molecular information products and services for global healthcare settings. The firm's also offers guidance to clinicians about life threatening infections, improving patient outcomes, and decreasing the spread of infections caused by multidrug-resistant microorganisms. Its products include Unyvero, Acuitas AMR Gene Panel and Acuitas Lighthouse, and the ARES Technology Platform including ARESdb, using NGS technology and AI-powered bioinformatics solutions for antibiotic response prediction. The company was founded on January 22, 2001 and is headquartered in Gaithersburg, MD.OLongby TheCryptoChartWhisperer113
OPGN 1M Decline -62% to $0.07. Rebound $0.14 and then $0.01Do you wear Fleece? Its going to be cold. OpGen, Inc. is a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease. It engages in the development of molecular information products and services for global healthcare settings. The firm's also offers guidance to clinicians about life threatening infections, improving patient outcomes, and decreasing the spread of infections caused by multidrug-resistant microorganisms. Its products include Unyvero, Acuitas AMR Gene Panel and Acuitas Lighthouse, and the ARES Technology Platform including ARESdb, using NGS technology and AI-powered bioinformatics solutions for antibiotic response prediction. The company was founded on January 22, 2001 and is headquartered in Gaithersburg, MD.OShortby TheCryptoChartWhispererUpdated 2
OPGN | Interesting Setup | WatchingOpGen, Inc., a precision medicine company, engages in developing and commercializing molecular microbiology solutions in the United States and internationally. Its product portfolio includes Acuitas AMR Gene Panel, an in vitro diagnostic (IVD) test for the detection and identification of various bacterial nucleic acids and genetic determinants of antimicrobial resistance (AMR) from bacterial colonies isolated from any specimen, as well as Curetis CE-IVD-marked polymerase chain reaction-based SARS-CoV-2 test kits. The company's products also comprise ARES Technology Platform, including ARES reference database on antimicrobial resistance using next generation sequencing technology and artificial intelligence powered bioinformatics solutions for antibiotic response prediction; and Unyvero Platform, an automated sample-to-answer molecular diagnostics platform that integrates automated sample preparation, analysis, and identification of disease relevant pathogens and antibiotic resistance markers. The company utilizes molecular diagnostics and informatics to help combat infectious diseases. It also helps clinicians with information about life threatening infections to enhance patient outcomes, and to decrease the spread of infections caused by multidrug-resistant microorganisms. OpGen, Inc. has a collaboration with the New York State Department of Health and ILUM Health Solutions, LLC to develop a research program to detect, track, and manage antimicrobial-resistant infections at healthcare institutions. The company was incorporated in 2001 and is headquartered in Rockville, Maryland.OLongby DivergenceSeeker110
OPGN 15min Scalpers editiontest OpGen, Inc. is a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease. It also engages in the development of molecular information products and services for global healthcare settings. It also offers guidance to clinicians about life threatening infections, improve patient outcomes, and decrease the spread of infections caused by multidrug-resistant microorganisms (MDROs). The firms products include Unyvero, Acuitas AMR Gene Panel and Acuitas Lighthouse, and the ARES Technology Platform including ARESdb, using NGS technology and AI-powered bioinformatics solutions for antibiotic response prediction. The company was founded on January 22, 2001 and is headquartered in Gaithersburg, MD.OShortby TheCryptoChartWhispererUpdated 3
OPGN. P-Modeling Pt X-1 The Cajun WaveFunction of WonderWelcome Hyperspace Travelers. This is going to be one of the most profitable trades I ever engage in. I wish you to join me at your own risk. I know you will doubt what I am about to say.. But that is the funny thing about my work. Your doubt is my gain. OPGN Is going to enter a miraculous depth defying parabolic move that will cement OPGN as a heavyweight bio-technology stock. Part One is +200%. Part Two is +200%. Part One of OPGN is now active. ______________________________________________ Holding 38,215 Shares of OPGN @ Entry Price between $2.10 - $2.12. _____________________________________________________________ Confirmation of TP is Equalization of Mean Reversion. $7.60 -$6.60 is LEVEL ONE TP. Satisfying this equalization level brings in just under a quarter million dollars profit. +200% This IDEA only shows TP LEVEL ONE. $7.60 - $6.60. This is +200% from out current price of $2.47. Once we satisfy this TP LEVEL ONE, I will release the Public Chart for satisfying TP LEVEL TWO @ $15.00 - $11.00 on OPGN. Once we satisfy TP LEVEL TWO, I will release the Public Chart for satisfying TP LEVEL THREE @ $35.00 - $28.00 on OPGN. This is the First Approximation of Mean Reversion on a 1 Hour Vector Segment. I expect a profit capture of over half a million dollars by the end of my Trade Sequence on OPGN alone. If I satisfy ALL my TP LEVEL's I will make a total of 1.3 million dollars on my investment. _______________________________ Technical Components Explained. _______________________________ A Wave Function is split into two components. The first component is the dynamic parametric describing an underlying functional connectivity between Slope (S), Velocity (V), Pressure (P) and Mean Equalization (||#) of an actualized binary {1001:0110} over Time (Y) within Segment (TF). The second component is a Cyclic Approximation of the cyclical momentum of angular spin along a equalizing binary string. These mechanics shown are used to decode a wave function of a ecosystem that is multidimensional and algorithmically controlled. Algorithmic mechanics yields astounding evidence of geometric structure affinity to these types of ecosystems based upon rudimentary binary code used to power these vessels of manipulation. Thus, application is warranted. The Mean Reversion is the mean of the Segment TF of an actualized string binary. I have decoded two sets of wavefunctions in OPGN that guide its algorithmic movement. I use a variety of parametrics to tease out the algorithmic movements into geometric approximations specific to OPGN's inherent functional connectivity. OPGN has achieved orthogonality. OPGN has satisfied a structural integrity of approximations. OPGN has satisfied lower level dimensional Mean Reversion Levels. OPGN has significant structural integrity. Look at OCT-NOV-DEC of 2019. We now have a PERFECT MATCH between the previous structure and our current structure. This is NOT a coincidence. Do your own research. OPGN is a powerhouse of catalysts. Welcome to Hyperspace. Welcome to the 4th Industrial Revolution. The Cybernetic Era of Advancement. OPGN will consistently GREEN in a sea of RED. Global Depression is imminent. OPGN is primed. As of today, they have net positive cash flow, with FDA approval imminent on their flagship AMR gene panel. Check Press Releases for Pipeline of incoming catalysts. Doubters will be cry. Holders will fly. Join the Glitch in Hyperspace. Thanks for Pondering the Unknown with Me, Glitch420 OLongby Glitch420Updated 10109
OPGN Action Close Up 1Wtest OPGEN INC. OpGen, Inc. is a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease. It also engages in the development of molecular information products and services for global healthcare settings. It also offers guidance to clinicians about life threatening infections, improve patient outcomes, and decrease the spread of infections caused by multidrug-resistant microorganisms (MDROs). OLongby TheCryptoChartWhisperer226
Zero hour The move today was solid, whether it be fomo for the possibility of a clearance decision to be made or valuation of the company starting to be realized, money will be made. I can’t be certain on what the future holds or if the FDA will clear the acuitas lighthouse product, but I have a positive outlook for this company. They have an S3 at the ready wanting to rake in as much as 150 million dollars (with preferred shares) If you haven’t already take a look into this company, make a choice, and take a chance. Low risk high rewards IMO. The trend is your friend and right now it’s up, I think we might see a continuation into the week, with everything lining up. OLongby Minimax21222
OPGN A Tale Of 2 FibsOPGN has slowly crept up ever since that insider buying in June. After meandering around the 786 fib line for weeks, the stock finally headed back toward that 618 fib line and...yet again...was rejected at that level. In general, momentum has been building in the stock but now with some attention, this 618 fib level could be an important one to keep an eye on for longs. You've also got the FDA review to think about as well. From June: " The company recently submitted an updated 510(k) summary to the FDA for its Acuitas AMR Gene Panel for isolates. It included all of the FDA’s previously requested updates and consistent with the FDA’s outlined timeline. OpGen was previously informed that the FDA intends to complete its review by the end of August ...Obviously, with infectious diseases taking up a lot of the news flow over the last year, diagnostics companies have grown in popularity. Along with subsidiaries Curetis GmbH and Ares Genetics GmbH, OpGen develops and commercializes molecular microbiology solutions to guide clinicians with rapid and actionable information about life-threatening infections...One of the main catalysts for this week is actually based on insider activity. A few Form 4s were filed on the 14th, showing insider buys this month. Both COO Johannes Bacher and CEO Oliver Schacht picked up a total of 40,000 shares for just over $90,000. Purchases were made at prices ranging from $2.22 to $2.30. " Quote Source & Read More: 5 Top Penny Stocks Insiders Decided To Buy In June 2021 Oby PennyStocks101222
OPGN UpdateSmall description on chart, I've done a lot of DD on this company. Very comfortable taking a position here again for a swing. This is all JMO, I am NOT a financial advisor. Please DYODD.OLongby Cogera111
OPGN - Long Setup Flag Play , Break above 2.65. Stop signal $2.40 Target 1 $3.08. Target 2 3.43.OLongby AcornWealthCorp112
OPGN IdeaMight be time to revisit OPGN, Chart loos great and company should be expecting FDA approval of their product relatively soon from what I'm reading. All JMO please DYODD. I am NOT a financial advisor.OLongby Cogera1
OPGN mega ascending triangleOPGN has been forming an enormous ascending triangle for over 18 months. Something similar happened with JILL and the breakout took it from 4's - 23.00. I expect a breakout of the ascending triangle that sends OPGN to around 8.00/share. Then I expect us to pause and consolidate before a run to fill the gap up to roughly 17.00 Manage your risk accordingly. I'm of the view that this has 5-8X potential from here.OLongby Nbhaines4
Clear pattern?We see there is clearly a trend here Resistance at 2.48 price range We break 2.48 the sky is the limit… or At least till it’s held down again lol Will continue to update as time goes by Catalysts to come. (FDA and subsequent launch of acuitas AMR gene panel, Chinese approval of cartridge for unyvero and subsequent launch, certificate of sale in Columbia. Also product launch from other portion of group company “ares genetics”) Make your move, load up, flip or hold on these news releases! OLongby Minimax212
Strength. Reached PT of 2.20, brought back down slowly at end of day and being manipulated during afterhours. Can’t stand it, but I won’t mind when news hits. More funds adding all throughout the month of may. We close higher on friday, PT for next week is 2.30 unless of course news hits lol (3day weekend) hope everyone who reads this has a blast! OLongby Minimax212
You can do it rocky!Opgen holding its ground. Had a few moments of weakness during afterhours trading this past week where she was pushed to 1.70’s fought right back with a slow grind up, Friday was a big day for This one, pushed right through resistance of 2.06 and hit 2.12. Likely to continue the upwards trend next week PT for next week 2.20’s waiting for 1 of 3 golden tickets to hit: - Chinese approval of unyvero cartridge, the last piece of the two part puzzle needed for this company. if approved a deal worth 180 million follows shortly after….System approved earlier in the year so not much else is required -FDA approval decision “possibly” at the end of august - distribution deal in Columbia OLongby Minimax21221
Where to next?OPGN just posted updated business update and earnings, -.24 in-line with earnings unlike the incorrect reporting done by Bazinga and Seeking alpha. What should be expected is that the trend for the next couple of weeks maybe months “if” no news, will be that the long term trendline holds and a slow increase in stock price. Be prepared for horrible market conditions, if you want to hold stops probably 1.90 so you don’t lose too much (if you’re a stop loss type of person of course) Buy limits ready around 1.70’s and 1.60’s... but I feel like it’s unlikely as the LT trendline held its own even with all the selling that was done today (but it’s better to be prepared) Best of luck, if I have any updates will give them as accordingly :) OLongby Minimax21330
Gap city blues!Daily chart presents some strength with recent news release relating to Opgen expanding testing in the state of New York with the use of their “Acuitas AMR gene panel” The product is (RUO) research use only, as is has not yet been approved by the FDA. I believe that with the current market, it’s highly likely that the gap should be filled within this week, and will likely see a move to higher price ranges wIth more and more investors expecting a favorable decision from the FDAOby Minimax21111
OPGN: Bullish Pennant (60%)Bullish Pennant (60%) Pros: Volume during post formation Descending volume during triangle formation Golden cross in blue PPS above 50MA and 200MA RS above 0 R/R ratio above 4 200MA ascending, barely Cons: ATR Flat/descending 250RSI below 50 and flat RS barely ascending Earning coming. May make it or break it. Target: PT = 4.79$ Help how ever you can to keep this alive. Thank you to those who have donated Coins! Always do your own due dilligence. This is not financial advice Stay Humble, have fun, make money! Education: www.dailyfx.com OLongby LeLaf115
Opgen, where is it headed?From a technical standpoint the chart on OPGEN looks like it will head upwards, but my personal opinion, I believe it is possible that the SP will take a dip in the following days with earnings report coming on March 25th; Alongside market uncertainty with treasury yields increasing, it’s possible that it heads to 1.90’s and even 1.80’s price points again. There’s a very significant gap around (2.05-2.20) on the daily and smaller timeframes... unless the potential FDA decision or NMPA approval comes soon it’s possible that the gap will be filled. OShortby Minimax210
OPGEN Harmonics: Target-Practice!!Come on over and shoot some fish in a barrel with me! Reload here!OLongby Antikythera_MechanismUpdated 551
Trade alert: OPGNPoints of interest on chart. We might have another day or two of movement upwards. This can go either way (predicted green and red zone in chart) Be careful! *Please leave a like if you find this useful, thanks*OLongby BeardedSince2210